Rx (Prescription Medicine)
USD $ 129.00
Nanoxel 30mg注射液是一种靶向疗法，用于治疗某些类型的癌症。其活性成分Nanoxel是一种强效化疗药物，通过干扰癌细胞的生长和分裂起作用。具体而言，它属于一类称为紫杉烷类的药物，这些药物会破坏微管的形成，而微管是细胞分裂的关键组成部分。通过阻止这些微管的正常形成和功能，Nanoxel会导致细胞周期停滞，最终引起快速分裂的癌细胞死亡。
Nanoxel 30mg注射液用于治疗多种恶性肿瘤，包括但不限于乳腺癌、卵巢癌和非小细胞肺癌。给药剂量和治疗时长由主治医生根据具体的癌症类型和阶段、患者的整体健康状况以及对疗法的反应来确定。该药物通过静脉注射在医疗监督下给予。
常见不良反应可能包括骨髓抑制（导致白细胞、红细胞和血小板计数下降）、脱发、疲劳、恶心、呕吐、腹泻以及周围神经病变。严重不良反应也可能发生，患者应立即向医疗提供者报告任何异常症状。Nanoxel 30mg注射液应储存在室温，避光保存，并放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Strength |
其他品牌的 Paclitaxel 30 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
